Clinical trial Recruiting at 1 site Interventional Ages 1 Year to 5 Men only

Sacral erector spinae plane block versus caudal epidural block for pain after hypospadias repair in young boys

Official title: Comparison of Preemptive Analgesic Effect of Ultrasound Guided Sacral Erector Spinae Plane Block Versus Ultrasound Guided Caudal Block in Pediatric Undergoing Hypospadias Surgery

Run by Tanta University · NCT07099560 · Data updated 2026-11-12

This trial will see if a sacral erector spinae plane block or a caudal epidural block gives better pain relief for boys aged 1–5 after hypospadias repair.

More Pain, Postoperative trials

Quick facts

Study typeInterventional
Ages1 Year to 5 Years
SexMen only
Enrollment70 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, El-Gharbia Govenorate)
StatusRecruiting
StartedApril 1, 2025
Main results expectedApril 2026
Study endsApril 2026
Registry record updatedSeptember 9, 2025
Trial IDNCT07099560 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Male children aged 1–5 years with ASA physical status I–II scheduled for elective hypospadias repair whose parent or legal guardian provides written informed consent are ideal candidates.

Probably not a fit

Children with coagulopathy, infection at the injection site, allergy to amide local anesthetics, neurologic or spinal anomalies, significant hepatic/renal/cardiac disease, or any other contraindication are not eligible and are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, parallel-group, assessor-blinded trial at Tanta University Hospital comparing ultrasound-guided sacral erector spinae plane block (sESPB) with ultrasound-guided caudal epidural block for postoperative analgesia in male children undergoing hypospadias repair. Seventy participants aged 1–5 will be randomized 1:1 to receive either sESPB or caudal block with 0.25% bupivacaine (0.5–1 mL/kg, maximum 20 mL) after induction of general anesthesia. The primary outcome is pain over the first 24 hours measured with the FLACC scale at prespecified time points; secondary outcomes include total opioid consumption, time to first rescue analgesia, postoperative nausea and vomiting, parent/guardian satisfaction, hemodynamic trends, and predefined adverse events. Perioperative care is standardized and rescue pethidine is given when FLACC ≥4 to manage breakthrough pain.

Why it matters

Potential benefit: If successful, sESPB could provide equal or better postoperative pain control with fewer adverse effects and lower opioid needs compared with caudal block.

How similar studies have gone: Caudal epidural block is well established for pediatric genitourinary surgery, while sacral ESPB is a newer regional technique with promising small series but limited direct comparative data in hypospadias repair.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Male children aged 1-5 years
* ASA physical status I-II
* Scheduled for elective hypospadias repair under general anesthesia
* Parent or legal guardian provides written informed consent
* Able to complete postoperative assessments through 24 hours after surgery Exclusion Criteria
* Parent/guardian refusal of participation
* Coagulopathy or current anticoagulant therapy
* Infection at the intended injection site (sacral/caudal region) or systemic infection
* Allergy/hypersensitivity to amide local anesthetics (e.g., bupivacaine) or study medications
* Neurologic or spinal disorders or congenital sacral anomalies affecting block safety
* Significant hepatic, renal, or cardiac disease
* Any other condition that, in the investigator's judgment, contraindicates caudal block or sacral ESPB or could interfere with safe participation

Where it's running

  • Tanta University Hospital
    Tanta, El-Gharbia Govenorate, Egypt
    Recruiting

Study contacts

  • Principal investigator: Ghada MA Elfekey, MBBCH — Faculty of Medicine, Tanta University, Egypt
  • Study coordinator: Ghada MA Elfekey, MBBCH
  • Email: ghadaelfekey0@gmail.com
  • Phone: +201271600557

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.